Livdelzi (seladelpar) is a medicine that can treat primary biliary cholangitis (PBC) by reducing the amount of bile in your body. It does this by signaling the body to stop making bile acid.

A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile ...

Your provider can view the inside of these organs and check for problems. Next, they will pass a tube through the scope and inject a dye into the ducts draining your liver (biliary ducts) and the duct ...